Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Apr. 13];7(6):s243. Available from: https://skin.dermsquared.com/skin/article/view/2358